T1	HMM 607 644	three-year relapse-free survival rate
T2	HMM 773 787	adverse events
T3	HMM 794 802	relapsed
T4	HMM 812 829	died of toxicity.
T5	HMM 941 950	relapsed.
T6	HMM 993 1002	relapsed.
T7	HMM 1017 1048	localized lymphoblastic disease
